ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Ultrasound"

  • Abstract Number: 0149 • ACR Convergence 2021

    Development of Joint Effusion, Hyperperfusion and Enthesitis After One Hour of Age-and Gender Adjusted Weight Training

    Julia Schreiner1, Dennis Scheicht2, Pantelis Karakostas3, Jana Ziob1, Charlotte Behning1, Peter Preuss4, Peter Brossart5 and Valentin Schäfer1, 1University Hospital Bonn, Bonn, Germany, 2Porz am Rhein Hospital, Cologne, Germany, 3Clinic of Internal Medicine III, Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Bonn, Germany, 4University of Bonn, Bonn, Germany, 5Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

    Background/Purpose: Ultrasound is an established tool to detect changes of joints, tendons and entheses in rheumatology. However, several studies detected structural and vascular changes in…
  • Abstract Number: 0312 • ACR Convergence 2021

    Prognostic Value of Salivary Gland Ultrasonography in Primary Sjögren’s Syndrome

    Francesco Ferro1, Gianmaria Governato1, Giovanni Fulvio1, Gaetano La Rocca1, Silvia Fonzetti1, Giacomo Aringhieri2, Valentina Donati3, Marta Mosca4 and Chiara Baldini5, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2University of Pisa, 3Diagnostic and Interventional Radiology, Department of Translational Research and of New Technologies in Medicine and Surgery, Pisa, Italy, 3AOUP, Unit of Pathological Anatomy, Pisa, Italy, 4Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 5University of Pisa, Pisa, Italy

    Background/Purpose: In the last decade, salivary gland ultrasonography (SGUS) has appeared as a useful tool for the diagnosis of primary Sjögren’s syndrome (pSS) and for…
  • Abstract Number: 1356 • ACR Convergence 2021

    Effects of TNF-α versus Secukinumab on Active Ultrasound Confirmed Enthesitis in Psoriatic Arthritis

    Ashley Elliott1, Gary Wright2, Adrian Pendleton2 and Madeleine Rooney1, 1Centre for Experimental Medicine , School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, UK, Belfast, Northern Ireland, United Kingdom, 2Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom

    Background/Purpose: Enthesitis is an important aspect of disease in PsA and its clinical assessment has problems in terms of sensitivity and overlap with alternative co-morbid…
  • Abstract Number: 0151 • ACR Convergence 2021

    Usefulness of Ultrasound and (FDG) PET/CT to Detect Cranial and Extracranial Artery Involvement in Patients with Suspected Large Vessel Vasculitis

    Juan Molina1, Isabel Castrejón2, Javier Rivera2, Julia Martínez Barrio2, Juan Carlos Nieto2, Katerine López2, Fernando Montero2, Laura Trives Folguera2, Carlos González3 and Jose Maria Alvaro-Gracia2, 1Hospital General Universitario Gregorio Maran, Madrid, Spain, 2Hospital General Universitario Gregorio Marañón, Madrid, Spain, 3CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    Background/Purpose: Ultrasound (US) is recommended as the first imaging modality to assess patients presenting with predominantly cranial symptoms of giant cell arteritis (GCA). However, its…
  • Abstract Number: 0313 • ACR Convergence 2021

    Do Primary Sjögren’s Syndrome Patients with Normal Major Salivary Gland Ultrasound Have Less Active Disease?

    Katja Perdan Pirkmajer1, Matija TOMSIC1 and Alojzija Hocevar2, 1University Medical Centre Ljubljana, Ljubljana, Slovenia, 2UKC Ljubjana, Ljubjana, Slovenia

    Background/Purpose: Ultrasonographically depicted morphological changes of major salivary glands (SG) have been recently correlated with the disease activity in primary Sjögren’s (pSS)1. The aim of…
  • Abstract Number: 1358 • ACR Convergence 2021

    Clusters of Psoriatic Arthritis Patients at Baseline Based on Different Ultrasound Detected Synovitis: Exploratory Analysis from a Phase III Study

    Maria Antonietta D'Agostino1, Georg Schett2, Corine Gaillez3, Philip Conaghan4, Esperanza Naredo5, Philippe Carron6, Ruben Burgos-Vargas7, Peter Mandl8, Javier Rosa9, Maarten Boers10, Punit Goyanka11, Weibin Bao12 and David Demanse3, 1Rheumatology, Fondazione Policlinico Universitario “Gemelli”, IRCCS, Rome, Italy, 2Universitätsklinikum Erlangen, Department of Internal Medicine 3 – Rheumatology and Immunology, Erlangen, Germany, Erlangen, Germany, 3Novartis Pharma AG, Basel, Switzerland, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz and Autónoma University, Madrid, Spain, 6Department of Rheumatology, University Hospital Ghent, University of Ghent, Ghent, Belgium, 7Department of Rheumatology, General Hospital of Mexico, Ciudad de Mxico, Mexico, 8Medical University of Vienna, Vienna, Austria, 9Rheumatology Unit, Internal Medical Services, and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 10Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 11Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India, 12Novartis, East Hanover, NJ

    Background/Purpose: Psoriatic arthritis (PsA) is characterized by inflammation of synovial membranes and entheseal sites leading to pain, structural damage, impairment of physical function and quality…
  • Abstract Number: 0153 • ACR Convergence 2021

    Echogenic and Hypervascular Synovium Detected on Ultrasound Are Predictive of a Favorable Response After Intra-articular Corticosteroid Injection in Patients with Knee Osteoarthritis

    Robert Dima1, Trevor Birmingham2, Ryan Pinto3, Holly Philpott1, McKenzie Carter1 and Tom Appleton2, 1Western University, London, ON, Canada, 2University of Western Ontario, London, ON, Canada, 3Western University, Kitchener, ON, Canada

    Background/Purpose: Intra-articular corticosteroids (IACS) are commonly used for symptom management in knee osteoarthritis (KOA) patients, despite the fact that many patients do not respond to…
  • Abstract Number: 0412 • ACR Convergence 2021

    Prevalence, Distribution, Clinical Correlates and Outcomes of Upper Extremity Macrovascular Disease in Systemic Sclerosis: Results from a Single Center Referral Cohort (2001-2018)

    Ashima Makol1, Caitrin Coffey1, Tina Gunderson1, Alicia Hinze1, Yasser Radwan2, Cynthia Crowson3, David Liedl1, Kenneth Warrington1 and Paul Wennberg1, 1Mayo Clinic, Rochester, MN, 2Michigan State University, Lansing, MI, 3Mayo Clinic, Eyota, MN

    Background/Purpose: To study the prevalence, anatomical distribution, clinical correlates and outcomes of macrovascular disease (MVD) on duplex ultrasound (US) of the upper extremity in Systemic…
  • Abstract Number: 1360 • ACR Convergence 2021

    Ultrasound Demonstrates Continued Improvement in Psoriatic Arthritis Synovitis and Enthesitis with Secukinumab: 52-week Results from a Phase III Study

    Maria Antonietta D'Agostino1, Georg Schett2, Corine Gaillez3, Carlos Guerrero4, PETRA HANOVA5, Tomas Cazenave6, Maria S. Stoenoiu7, Marina Backhaus8, Gael Mouterde9, Maarten Boers10, Anne-Marie Duggan11, Punit Goyanka12 and Philip Conaghan13, 1Rheumatology, Fondazione Policlinico Universitario “Gemelli”, IRCCS, Rome, Italy, 2Universitätsklinikum Erlangen, Department of Internal Medicine 3 – Rheumatology and Immunology, Erlangen, Germany, Erlangen, Germany, 3Novartis Pharma AG, Basel, Switzerland, 4Dermatologico Country, Jalisco, Mexico, 5Department of Rheumatology, Institute of Rheumatology, Prague, Czech Republic, 6Instituto de Rehabilitación Psicofisica, Buenos Aires, Argentina, Buenos Aires, Argentina, 7Rheumatology department, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 8Department of Internal Medicine, Rheumatology and Clinical Immunology, Park-Klinik Weissensee Academic Hospital of the Charité, Berlin, Germany, Berlin, Germany, 9Rheumatology department, CHU Montpellier, Montpellier, France, 10Department of Epidemiology and Data Science, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 11Novartis Ireland Limited, Dublin, Ireland, Dublin, Ireland, 12Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India, 13Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Power Doppler ultrasound (PDUS) is a sensitive non-invasive imaging tool to visualize a wide range of articular and periarticular inflammation in psoriatic arthritis (PsA).1,2…
  • Abstract Number: 0156 • ACR Convergence 2021

    Tenosynovitis Detected by Power Doppler Ultrasound: A Differential Feature of Patients with Seronegative Rheumatoid Arthritis

    Einer Sanchez Prado1, Santiago Ruta2, Laura Cuellar1, Sebastian Magri3 and Rodrigo Garcia Salinas4, 1Hospital Italiano La Plata, La Plata, Argentina, 2Hospital San Martin de La Plata, La Plata, Argentina, 3Hospital Italiano La Plata, La Plata, 4Hospital Italiano de La Plata, La Plata, Argentina

    Background/Purpose: It is known that seronegative rheumatoid arthritis has different characteristics from seropositive RA. Objectives: To estimate the frequency of rheumatoid arthritis (RA) in a…
  • Abstract Number: 0466 • ACR Convergence 2021

    Subclinical Large Vessel Vasculitis in Polymyalgia Rheumatica

    Eugenio De Miguel1, Pierluigi Macchioni2, Edoardo Conticini3, Corrado Campochiaro4, Rositsa Karalilova5, Giulia Klinowski2, Paolo Falsetti3, Irene Monjo6, Alessandro Tomelleri7, Zguro Batalov5 and Alojzija Hocevar8, 1Hospital Universitario La Paz, Madrid, Spain, 2Department of Rheumatology, IRCCS-S.Maria Nuova, Reggio Emilia, Italy, 3Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy, 4Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR). San Raffaele Scientific Institute, Milan. Italy, Milan, Italy, 5Medical University of Plovdiv, University Hospital Kaspela, Plovdiv, Bulgaria, 6Hospital La Paz - IdiPAZ, Madrid, Spain, 7Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR). San Raffaele Scientific Institute, Milan, Milan, Italy, 8UKC Ljubjana, Ljubjana, Slovenia

    Background/Purpose: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are closely related diseases. PMR occurs in approximately 50 % of GCA patients1, however the frequency…
  • Abstract Number: 1394 • ACR Convergence 2021

    Vascular Ultrasound for Giant Cell Arteritis: An Effective Diagnostic Modality for a Fast Track Clinic in the United States

    Charlie Oshinsky1, Alison Bays1, Ingeborg Sacksen2, Elizabeth Jernberg3, Eugene zierler1, Andreas Diamantopoulos4 and Scott Pollock1, 1University of Washington, Seattle, WA, 2University of Washington, Bellingham, WA, 3Virginia Mason Medical Center, Seattle, WA, 4Akerhus University Hospital, Brum, Norway

    Background/Purpose: Giant cell arteritis (GCA) is the most common form of large vessel vasculitis. Prompt diagnosis and treatment of GCA is vital to prevent vision…
  • Abstract Number: 0163 • ACR Convergence 2021

    Diagnosis of Giant Cell Arteritis in Spain: Data from the ARTESER Registry

    Eugenio De Miguel1, Jesús T. Sánchez-Costa2, Javier Narvaez3, Miguel Ángel gonzalez-Gay4, Noemí Garrido-Puñal5, Paula V. Estrada-Alarcon6, Iñigo Hernández-Rodríguez7, Elisa Fernández-Fernández8, María T. Silva-Diaz9, Jesús A. Valero-Jaimes10, Ismael González-Fernández11, Julio Sánchez12, Judit Lluch13, Eva Galindez-Agirregoikoa14, Javier Mendizábal-Mateos15, Luis Rodriguez Rodriguez16, Javier Loricera García17, Alejandro Muñoz18, Santos Castañeda19, Patricia Moya20, Patricia Morán-Álvarez21, Vanessa A. Navarro-Angeles6, Joan Calvet-Fontova22, Ivette Casafont23, Francisco Ortiz-Sanjuán24, Selene Labrada-Arrabal25, Cristina Campos-Fernández26, María Alcalde-Villar27, Antonio Juan-Mas28 and Ricardo Blanco29, 1Hospital Universitario La Paz, Madrid, Spain, 2Spanish Society of Rheumatology, Madrid, Spain, 3Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 4Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 5Hospital Universitario Virgen del Rocío, Sevilla, Spain, 6Hospital de Sant Joan Despí Moisès Broggi. Sant Joan Despí, Barcelona, Spain, 7Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 8Rheumatology department, La Paz University Hospital, Madrid, Spain, 9Complejo Hospitalario Universitario de La Coruña, Coruña, Spain, 10Hospital Universitario Donostia, Donostia-San Sebasti, Spain, 11Hospital Universitario de León, León, Spain, 12Hospital Universitario 12 de Octubre, Madrid, Spain, 13Hospital Universitari Bellvitge, Hospitalet de Llobregat, Spain, 14Hospital Universitario de Basurto, Bilbao, Spain, 15H. Navarra, Navarra, Spain, 16Hospital Clinico San Carlos, Madrid, Spain, 17Hospital Universitario Marqués de Valdecilla, Santander, Spain, 18Hospital Universitario Virgen del Rocío, Sevial, Spain, 19Hospital Universitario de la Princesa, Madrid, Spain, 20Hospital Sant Pau, Barcelona, Spain, 21Hospital Universitario Ramón y Cajal, Madrid, Spain, 22Hospital Universitari Parc Tauli, Sabadell, Spain, 23Hospital Universitari Germans Trias i Pujol, Barcelona, Badalona, Spain, 24H. La Fe, Valencia, Spain, 25Hospital del Mar, Barcelona, Spain, 26Consorci Hospital General Universitari de Valencia, Valencia, Spain, 27Hospital Universitario Severo Ochoa, Leganés, Spain, 28Hospital Universitario Son Llàtzer, Palma de Mallorca, Spain, 29Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: To standardize research studies different classification systems are used. Currently, the ACR Giant Cell Arteritis (GCA) 19901 classification criteria is probably the most widely…
  • Abstract Number: 0793 • ACR Convergence 2021

    Contributing Factors of Good Outcome in Difficult-to-treat Rheumatoid Arthritis: A Multicenter RA Ultrasound Prospective Observational Cohort Study in Japan

    Shin-ya Kawashiri1, Tohru Michitsuji1, Yushiro Endo1, Ayako Nishino1, Toshimasa Shimizu1, Remi Sumiyoshi1, Tomohiro Koga1, Naoki Iwamoto1, Kunihiro Ichinose2 and Atsushi Kawakami1, 1Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Nagasaki University Graduate School of Biomedical Sciences, Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki, Japan

    Background/Purpose: The concept of difficult-to-treat rheumatoid arthritis (D2T RA) has emerged as the greatest unmet need in recent years. We have investigated the clinical characteristics…
  • Abstract Number: 1403 • ACR Convergence 2021

    Giant Cell Arteritis Subtypes: Data from the ARTESER Registry

    Eugenio De Miguel1, Jesús T. Sánchez-Costa2, Javier Narvaez3, Miguel Ángel gonzalez-Gay4, Noemí Garrido-Puñal5, Paula V. Estrada-Alarcon6, Rafael B. Melero-González7, Elisa Fernández-Fernández8, María T. Silva-Diaz9, Joaquín M. Belzunegui10, Clara Moriano11, Julio Sánchez12, Judit Lluch13, Itziar Calvo14, Vicente Aldasoro15, Leticia León-Mateos16, Javier Loricera García17, Alberto Ruíz-Román5, Cristina Valero-Martínez18, Patricia Moya19, Marina Tortosa-Cabañas20, Vanessa A. Navarro-Angeles6, Carles Galisteo21, Anne Riveros-Frutos22, Jose A. Román-Ivorra23, Selene Labrada-Arrabal24, Margarida Vasques-Rocha25, Carlota L. Iñiguez-Ubiaga26, María García-González27 and Ricardo Blanco28, 1Hospital Universitario La Paz, Madrid, Spain, 2Spanish Society of Rheumatology, Madrid, Spain, 3Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 4Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 5Hospital Universitario Virgen del Rocío, Sevilla, Spain, 6Hospital de Sant Joan Despí Moisès Broggi. Sant Joan Despí, Barcelona, Spain, 7Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 8Rheumatology department, La Paz University Hospital, Madrid, Spain, 9Complejo Hospitalario Universitario de La Coruña, Coruña, Spain, 10Hospital Universitario Donostia, Donostia-San Sebasti, Spain, 11Hospital Universitario de León, León, Spain, 12Hospital Universitario 12 de Octubre, Madrid, Spain, 13Hospital Universitari Bellvitge, Hospitalet de Llobregat, Spain, 14Basurto University Hospital, Bilbao, Spain, 15Complejo Hospitalario de Navarra, Pamplona, Spain, 16Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, 17Hospital Universitario Marqués de Valdecilla, Santander, Spain, 18Hospital Universitario de La Princesa, Madrid, Spain, 19Hospital Sant Pau, Barcelona, Spain, 20Hospital Universitario Ramón y Cajal, Madrid, Spain, 21Hospital Universitari Parc Tauli, Saadell, Spain, 22Hospital Germans Trias i Pujol, Badalona, Spain, 23Hospital Universitari i Politècnic La Fe, Valencia, Spain, 24Hospital del Mar, Barcelona, Spain, 25Hospital Universitario Araba, Vitoria-Gasteiz, Spain, 26Hospital Universitario Lucus Augusti, Lugo, Spain, 27Hospital Universitario de Canarias, La Laguna, Spain, 28Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Giant cell arteritis (GCA) is the most common systemic vasculitis over 50 years of age. Classically, GCA was assimilated with the involvement of the…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology